Rogers (ROG) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 execution was solid, with net sales of $214.2M, up 0.4% sequentially, driven by EMS growth and record EV/HEV sales, but tempered by lower AES and general industrial demand; results met expectations and gross margin performance exceeded guidance high end.
Operational excellence initiatives, cost reductions, and additional manufacturing footprint actions, especially in ceramic operations, drove margin improvement.
Innovation remains a strategic focus, with R&D consolidation and new technology development underway, including the exit of the Northeastern University R&D location.
Capacity expansion continues, notably with a new ceramic power substrate facility in China, expected to begin mass production in mid-2025.
Demand remained uneven, with higher sales in key markets offset by elevated customer inventory levels.
Financial highlights
Net sales for Q2 were $214.2M, nearly flat sequentially, but down 7.2% year-over-year; gross margin reached 34.1%, up from 32.0% in Q1.
Adjusted net income was $12.8M; adjusted EPS was $0.69, up from $0.58 in Q1; GAAP net income was $8.1M, EPS $0.44.
Adjusted EBITDA was $31.9M (14.9% margin), up from $28.3M in Q1, but down from $43.7M in Q2 2023.
Operating cash flow was $23M; free cash flow was $8.8M; cash balance at quarter-end was $119.9M.
Capital expenditures were $14.1M in Q2, with full-year CapEx expected at $55M–$65M.
Outlook and guidance
Q3 2024 net sales expected between $215M–$225M, with gross margin guidance of 34.0%–35% and adjusted EPS of $0.75–$0.95, including restructuring charges for AES Belgium wind-down.
Q3 GAAP EPS forecasted at $0.32–$0.52.
Full-year capital spending projected at $55M–$65M, funded by operations and cash on hand.
H2 EMS sales expected to be stronger than H1, but AES recovery remains uncertain due to ceramic inventory overhang.
Full-year tax rate projected at 26%–27%.
Latest events from Rogers
- Q4 sales and margins rose on cost savings; 2026 outlook projects continued growth.ROG
Q4 202518 Feb 2026 - Q4 results met guidance; cost controls and innovation support H2 2025 recovery plans.ROG
Q4 20243 Feb 2026 - Strong growth in EV and high-tech markets, with margin expansion and global innovation focus.ROG
Stifel 2024 Cross Sector Insight Conference31 Jan 2026 - Earnings beat guidance, but sales fell on weak EV/HEV demand; Q4 outlook remains cautious.ROG
Q3 202418 Jan 2026 - Q1 2025 sales fell but cash rose; Q2 guidance stable despite ongoing tariff risks.ROG
Q1 202527 Dec 2025 - Operational improvements and innovation in high-growth markets drive optimism for H2 recovery.ROG
Gabelli Funds' 16th Annual Specialty Chemicals Symposium19 Dec 2025 - Annual meeting to elect nine directors, ratify PwC, and approve executive pay, with strong governance focus.ROG
Proxy Filing2 Dec 2025 - Director elections, auditor ratification, and say-on-pay up for vote at May 2025 meeting.ROG
Proxy Filing2 Dec 2025 - Q2 2025 saw sequential sales growth, curamikⓇ impairments, and major restructuring.ROG
Q2 202516 Nov 2025